Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
18%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
17%
ALSO IN PBE
PBE
28
HOLDINGS
50%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
| UNITED THERAPEUTICS CORP | 2.2% | 3.7% | 2.2% | |
| IONIS PHARMACEUTICALS, INC. | 2.1% | 4.2% | 2.1% | |
| VERACYTE INC | 2.1% | 3.2% | 2.1% | |
| GILEAD SCIENCES INC | 1.9% | 4.6% | 1.9% | |
| VERICEL CORPORATION | 1.8% | 2.3% | 1.8% | |
WDNA Overweight Relative to PBE
| NATERA INC | 4.4% | |
| BRIDGEBIO PHARMA, INC. | 4.0% | |
| BLUEPRINT MEDICINES CORP. | 3.8% | |
| NOVOZYMES A/S-B SHARES | 3.2% | |
| ALNYLAM PHARMACEUTICALS INC | 3.0% | |
| STOKE THERAPEUTICS, INC. | 2.3% | |
| ELI LILLY & CO | 2.3% | |
| TWIST BIOSCIENCE CORP. | 2.2% | |
| AGIOS PHARMACEUTICALS INC | 2.1% | |
| NOVARTIS AG | 1.9% |
WDNA Underweight Relative to PBE
| INCYTE CORP | -4.8% | |
| BIOGEN IDEC INC | -4.8% | |
| ROYALTY PHARMA PLC CLASS A | -4.7% | |
| ILLUMINA INC | -4.0% | |
| REGENERON PHARMACEUTICALS | -3.8% | |
| VERTEX PHARMACEUTICALS INC | -3.4% | |
| PTC THERAPEUTICS INC | -3.4% | |
| AMGEN INC | -3.4% | |
| SAREPTA THERAPEUTICS INC | -2.9% | |
| GILEAD SCIENCES INC | -2.7% |